Roche Launches Phase 2 TARBELA-AD Trial of NLRP3 Inhibitor in Alzheimer Disease
Source: NeurologyLive Published 17 Nov 2026 Imported 17 Nov 2026 Relevancy: Not reviewed
Read the articleSource: NeurologyLive Published 17 Nov 2026 Imported 17 Nov 2026 Relevancy: Not reviewed
Read the articleAll comments are reviewed before being published. Most comments are approved unless they are clearly inappropriate or unsafe.